Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (1349.HK) HKSE
2.97
+0.05(+1.71%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.97
+0.05(+1.71%)
Currency In HKD
| Market Cap | 2.62B |
| Enterprise Value | 2.62B |
| P/E Ratio | -91.52 |
| PEG Ratio | 3.66 |
| Price/Sales Ratio | 1.34 |
| Price/Book Ratio | 6.38 |
| Enterprise/Revenue | -0.27 |
| Enterprise/EBITDA | 1.84 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -0.23 |
| Operating Margin | -0.24 |
| Return On Assets | -0.06 |
| Return On Equity | -0.07 |
| Revenue | 668.05M |
| Revenue/Share | 0.38 |
| Gross Profit | 0 |
| EBITDA | -151.38M |
| Net Income | -153.36M |
| Diluted EPS | -0.14 |
| Total Cash | 1.12B |
| Total Cash/Share | 0.62 |
| Total Debt | 15.95M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.68 |
| Book Value Per Share | 1.25 |
| 52-Week Change | 14.67 |
| 52-Week High | 5.29 |
| 52-Week Low | 2.13 |
| Moving Average 50 Days | 3.09 |
| Moving Average 200 Days | 3.35 |
| Average Volume | 1.8M |
| Shares Outstanding | 340M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.05 |
| Trailing Annual Dividend Yield | 0.63 |
| Payout Ratio | -0.59 |
| Last Split Factor | N/A |
| Last Split Date | N/A |